Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Acute Pancreatitis II: Clinical Manifestations and Management01:30

Acute Pancreatitis II: Clinical Manifestations and Management

132
Acute pancreatitis presents a complex medical emergency characterized by rapid onset inflammation of the pancreas, demanding timely diagnosis and management to prevent complications. The condition primarily manifests through severe upper abdominal pain that often radiates to the back. This pain intensifies following the consumption of fatty foods. Accompanying symptoms such as nausea, vomiting, abdominal distention, fever, dyspnea, cyanosis, and jaundice can vary in intensity but significantly...
132
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

97
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
97
Acute Pancreatitis I: Introduction01:27

Acute Pancreatitis I: Introduction

381
Pancreatitis is inflammation of the pancreas, an organ located behind the stomach. It can be either acute or chronic.
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
381
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

96
The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
96
Gastritis III: Clinical Manifestations and Management01:23

Gastritis III: Clinical Manifestations and Management

307
The clinical manifestations of gastritis can vary depending on the cause and type of gastritis, but some common symptoms may include the following.
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
307
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

108
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
108

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Risk Factors and Clinical Predictors of Drug-Induced Hepatotoxicity in Patients Receiving First-Line Anti-tuberculosis Therapy.

Cureus·2026
Same author

GPR120/free fatty acid receptor 4 (FFAR-4) agonists, antagonists, allosteric modulators: Computational drug design and discovery review.

European journal of medicinal chemistry·2026
Same author

Incidence and Predictors of Acute Respiratory Distress Syndrome in Patients With Sepsis: A Two-Year Prospective Cohort Study From Khyber Pakhtunkhwa, Pakistan.

Cureus·2026
Same author

Challenging Anticoagulation With Warfarin and Heparin Following Mechanical Mitral Valve Replacement in a Patient With Infective Endocarditis: A Case Report Highlighting Diagnostic Difficulties.

Clinical case reports·2026
Same author

Tailoring of amino functionalized graphene oxide/cellulose/chitosan composite for the determination of imidacloprid in milk samples.

International journal of biological macromolecules·2026
Same author

Observation-based evidence reveals increased control of tree traits rather than hydroclimate on tree transpirational cooling across global regions.

Journal of environmental management·2026

Related Experiment Video

Updated: Jul 14, 2025

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
06:35

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice

Published on: June 28, 2021

4.1K

Hypertriglyceridaemia Induced Pancreatitis Management: A Case Report.

Aisha Kulsoom Mufti1, Naqeeb Ullah1, Muhammad Hayat1

  • 1Department of Anaesthesia, Northwest General Hospital,Peshawar,Pakistan.

JPMA. the Journal of the Pakistan Medical Association
|October 11, 2023
PubMed
Summary

Hypertriglyceridaemia-induced pancreatitis (HTAP) is a severe condition increasingly linked to lifestyle factors. This case report highlights the challenges in urgently treating HTAP due to limited evidence and invasive procedures.

Keywords:
Hypertriglyceridaemia induced Acute pancreatitis (HTAP), Lipoprotein lipase (LPL), Triglycerides (TG), Deep vein thrombosis (DVT), Systemic inflammatory response syndrome (SIRS), Hypertriglyceridaemia (HTG), Infusions, Intravenous (IV).

More Related Videos

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
07:10

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Published on: April 1, 2022

4.3K
Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
07:38

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

614

Related Experiment Videos

Last Updated: Jul 14, 2025

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice
06:35

Sodium Taurocholate Induced Severe Acute Pancreatitis in C57BL/6 Mice

Published on: June 28, 2021

4.1K
Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct
07:10

Establishment of a Mouse Severe Acute Pancreatitis Model using Retrograde Injection of Sodium Taurocholate into the Biliopancreatic Duct

Published on: April 1, 2022

4.3K
Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection
07:38

Preparing a Mice Model of Severe Acute Pancreatitis via a Combination of Caerulein and Lipopolysaccharide Intraperitoneal Injection

Published on: May 10, 2024

614

Area of Science:

  • Endocrinology and Metabolism
  • Gastroenterology

Background:

  • Acute pancreatitis is a serious condition with high mortality.
  • Gallstones and alcohol are primary causes, but lifestyle factors are increasing Hypertriglyceridaemia-induced pancreatitis (HTAP).
  • HTAP is often more severe than pancreatitis from other causes.

Observation:

  • A case report details a patient presenting with severe HTAP.
  • Physicians faced a dilemma in choosing urgent yet minimally invasive treatments.
  • Paucity of evidence complicates treatment decisions for HTAP.

Findings:

  • Hypertriglyceridaemia-induced pancreatitis presents unique challenges in management.
  • Treatment options for HTAP are diverse but carry varying risks and efficacy.
  • Balancing urgent intervention with procedural invasiveness is critical.

Implications:

  • This case underscores the need for further research into effective HTAP treatments.
  • Improved understanding of HTAP pathophysiology can guide clinical practice.
  • Developing evidence-based guidelines for HTAP management is crucial for improving patient outcomes.